Analysts See $-0.14 EPS for Check-Cap Ltd. (CHEK); 0 Bullish Analysts Covering AeroVironment, Inc. (AVAV)

February 10, 2018 - By Marie Mckinney

Among 6 analysts covering AeroVironment (NASDAQ:AVAV), 0 have Buy rating, 1 Sell and 5 Hold. Therefore 0 are positive. AeroVironment had 24 analyst reports since August 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, August 30 by Piper Jaffray. Canaccord Genuity maintained AeroVironment, Inc. (NASDAQ:AVAV) on Thursday, August 10 with “Hold” rating. Canaccord Genuity maintained the stock with “Hold” rating in Wednesday, September 2 report. The rating was downgraded by on Monday, July 3 to “”. The stock has “Overweight” rating by Piper Jaffray on Monday, September 14. Robert W. Baird maintained the shares of AVAV in report on Monday, October 23 with “Hold” rating. The rating was upgraded by Zacks on Friday, August 21 to “Sell”. The firm has “Hold” rating by Jefferies given on Wednesday, August 2. The firm earned “Hold” rating on Friday, June 23 by Jefferies. The rating was maintained by Robert W. Baird with “Hold” on Wednesday, December 6. See AeroVironment, Inc. (NASDAQ:AVAV) latest ratings:

05/12/2017 Broker: Canaccord Genuity Rating: Hold New Target: $50.0 Maintain
06/12/2017 Broker: Robert W. Baird Rating: Hold New Target: $50.0 Maintain
06/12/2017 Broker: Piper Jaffray Rating: Hold New Target: $42.0 Maintain
06/12/2017 Broker: Raymond James Rating: Hold
23/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $35.0 Maintain
06/10/2017 Broker: Jefferies Rating: Hold New Target: $37.0 Maintain
04/10/2017 Broker: Canaccord Genuity Rating: Hold Old Target: $40 New Target: $48 Maintain
30/08/2017 Broker: Piper Jaffray Rating: Hold New Target: $36.0 Maintain
30/08/2017 Broker: Canaccord Genuity Rating: Hold Old Target: $35 New Target: $40 Maintain
28/08/2017 Broker: Robert W. Baird Rating: Hold New Target: $35.0 Maintain

Analysts expect Check-Cap Ltd. (NASDAQ:CHEK) to report $-0.14 EPS on March, 8.They anticipate $0.01 EPS change or 6.67% from last quarter’s $-0.15 EPS. After having $-0.13 EPS previously, Check-Cap Ltd.’s analysts see 7.69% EPS growth. The stock decreased 8.33% or $0.06 during the last trading session, reaching $0.66. About 147,664 shares traded. Check-Cap Ltd. (NASDAQ:CHEK) has declined 2.26% since February 10, 2017 and is downtrending. It has underperformed by 18.96% the S&P500.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. The company has market cap of $12.72 million. The Company’s C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. It currently has negative earnings.

Among 4 analysts covering Check-Cap (NASDAQ:CHEK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Check-Cap had 11 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Check-Cap Ltd. (NASDAQ:CHEK) has “Buy” rating given on Thursday, October 8 by Maxim Group. On Friday, May 20 the stock rating was maintained by Chardan Capital Markets with “Buy”. The firm earned “Buy” rating on Friday, August 11 by H.C. Wainwright. H.C. Wainwright maintained the shares of CHEK in report on Thursday, January 11 with “Buy” rating. The stock of Check-Cap Ltd. (NASDAQ:CHEK) earned “Buy” rating by H.C. Wainwright on Thursday, September 28. As per Wednesday, March 16, the company rating was maintained by Chardan Capital Markets. On Tuesday, January 19 the stock rating was maintained by Maxim Group with “Buy”. The rating was maintained by Maxim Group on Tuesday, May 30 with “Buy”. As per Wednesday, July 22, the company rating was maintained by Chardan Capital Markets. Rodman & Renshaw initiated it with “Buy” rating and $6 target in Thursday, January 19 report.

Investors sentiment decreased to 1.87 in Q3 2017. Its down 0.27, from 2.14 in 2017Q2. It fall, as 13 investors sold AeroVironment, Inc. shares while 33 reduced holdings. 35 funds opened positions while 51 raised stakes. 17.13 million shares or 5.16% less from 18.06 million shares in 2017Q2 were reported. Eam Invsts Limited Liability Corp stated it has 0.32% in AeroVironment, Inc. (NASDAQ:AVAV). Gotham Asset Limited holds 0.02% in AeroVironment, Inc. (NASDAQ:AVAV) or 25,415 shares. Raymond James Associates reported 6,351 shares. Hutchin Hill Limited Partnership accumulated 13,100 shares. Northern Trust Corp stated it has 0% in AeroVironment, Inc. (NASDAQ:AVAV). Jane Street Group Inc Llc, New York-based fund reported 6,727 shares. Suntrust Banks invested in 0% or 8,636 shares. Vident Invest Advisory Limited Company invested in 1.39% or 474,428 shares. Baystate Wealth Ltd Liability Corp holds 0% of its portfolio in AeroVironment, Inc. (NASDAQ:AVAV) for 100 shares. Bankshares Of Nova Scotia invested in 0.01% or 28,810 shares. Financial Bank Of Montreal Can holds 0% of its portfolio in AeroVironment, Inc. (NASDAQ:AVAV) for 680 shares. Connors Investor Services Inc accumulated 83,378 shares. Thrivent Fin For Lutherans holds 0% of its portfolio in AeroVironment, Inc. (NASDAQ:AVAV) for 13,000 shares. Argent Cap Lc reported 41,145 shares. Awm Inv holds 1.46% of its portfolio in AeroVironment, Inc. (NASDAQ:AVAV) for 154,621 shares.

The stock increased 4.28% or $1.97 during the last trading session, reaching $47.98. About 327,911 shares traded. AeroVironment, Inc. (NASDAQ:AVAV) has risen 11.69% since February 10, 2017 and is uptrending. It has underperformed by 5.01% the S&P500.

Since August 22, 2017, it had 0 buys, and 8 selling transactions for $3.09 million activity. 7,600 AeroVironment, Inc. (NASDAQ:AVAV) shares with value of $373,426 were sold by Conver Timothy E.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: